Societe Generale Corporate & Investment Banking announces a new set-up for Healthcare and Chemicals sectors within Corporate Finance in Germany
Societe Generale Corporate & Investment Banking (SG CIB) announces a new set-up for its Healthcare and Chemicals sectors within Corporate Finance in Germany covering clients on a global level :
Christopher B. Riley is appointed Head of Corporate Finance for the Chemicals sector, effective from April 20, 2015. He will be responsible on a global level for the sector that has been transferred from London to Frankfurt. Previously, he worked for Moelis & Company and most recently as an independent advisor to various businessowners and investors.
Jesús Carrasco Abad is promoted Head of Corporate Finance for the Healthcare sector, which is already covered from Germany. Jesus joined SG CIB in October 2012 as a member of the international Healthcare team within Corporate Finance.
Based in Frankfurt, both will report to Axel-Sven Malkomes who will supervise both sector teams as Head of Corporate Finance for the Healthcare & Chemicals sectors. He was formerly Head of Corporate Finance for the Healthcare sector since February 2010.
The Chemicals industry is an important sector for Germany and is complementary with the healthcare sector. The department offers a global advisory approach, from Mergers & Acquisitions advisory to capital markets solutions, at both local and international levels.
With this announcement, SG CIB strengthens its Healthcare and Chemicals sector capabilities as well as its German platform, and enhances its offering to clients.